Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayla Sage

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Neurology|May 26, 2021
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility TrialMarcus W Koch, Kayla Sage, Sharanjit Kaur, et al.
Annals of Neurology|September 30, 2021
Hydroxychloroquine for Primary Progressive Multiple SclerosisMarcus W Koch, Sharanjit Kaur, Kayla Sage, et al.
Stroke|June 24, 2026
Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods StudyBogna A Drozdowska, William Betzner, Nora Cristall, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Neurology|May 26, 2021
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility TrialMarcus W Koch, Kayla Sage, Sharanjit Kaur, et al.
Annals of Neurology|September 30, 2021
Hydroxychloroquine for Primary Progressive Multiple SclerosisMarcus W Koch, Sharanjit Kaur, Kayla Sage, et al.
Stroke|June 24, 2026
Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods StudyBogna A Drozdowska, William Betzner, Nora Cristall, et al.
Pageof 1